Skip to main content
Main analysis: Spring Ventures in 2025: Cheap on the screen, still waiting for proof
ByMarch 31, 2026~9 min read

Spring: Is the UK pivot a new return engine, or just imported beta

In 2025, Spring turned listed UK tech vehicles from a side pocket into a meaningful portfolio leg. The question now is whether that shift improves value capture, or simply makes reported earnings more dependent on London, sterling, and Molten.

CompanySpring

The main article already established that Spring entered 2025 with a healthy liquidity cushion and a private portfolio the market still struggles to price properly. This follow-up isolates one layer only: the declared shift toward the UK and toward listed technology investment vehicles, with Molten at the center of the move.

This is no longer a side note in the filing. In one year, the company's investment in listed technology funds and companies rose from NIS 3.2 million to NIS 15.1 million. Molten alone ended the year at NIS 9.7 million, or roughly 64% of that bucket. At the same time, the company is not just buying London-listed paper from afar: it states that it set up Spring Next Tech in England in 2024, expanded its activity in 2025, plans to keep expanding in 2026, and has the CEO devoting most of his time to building that operation.

There is a real business logic here. Through listed UK vehicles, Spring gets broader exposure to private technology companies, with liquidity and diversification that direct holdings do not always provide. But 2025 also shows the cost: net profit still depended mainly on mark-to-market gains, most of the proof came in the second half, there is no FX hedge, and Molten concentration is high. At this stage, it is hard to describe the UK tilt as a proven return engine. It looks more like a capital-allocation bet that may work, but one that already imports London's market beta and sterling exposure into the P&L.

What actually changed in 2025

The 2025 move is not just geographic expansion. It is a change in portfolio character. The company explicitly says it plans to expand investments in listed technology funds and companies, partly because of liquidity and diversification, with a focus on the European market and especially the UK. That means moving from a book driven mainly by fair values of private holdings into a mix that lets quoted market prices flow much more directly into reported earnings.

The numbers make that shift clear. At the end of 2024, the company held only NIS 3.2 million in listed technology funds and companies. By the end of 2025, that figure had reached NIS 15.1 million, a rise of roughly 374%. That is already 32% of the quoted-securities portfolio and about 18.6% of equity. In other words, this is no longer a small experiment. It is a meaningful capital-allocation choice.

How the quoted-securities portfolio changed in 2025

The more interesting point is concentration. Spring does hold 7 listed technology investment companies and funds in England, but Molten is the dominant position. Its value reached NIS 9.7 million, roughly 64% of that public-tech bucket, about 20.6% of total quoted securities, and roughly 12% of equity. So the real question is not just whether Spring moved into the UK. It is whether it truly built a diversified public basket, or whether it concentrated a large part of that public move into one holding.

The other major change is currency. Net financial assets linked to sterling rose from NIS 10.0 million at the end of 2024 to NIS 23.3 million at the end of 2025, up more than 130%. This is not only an asset-selection story. It is also a currency-selection story.

Why this move could improve value capture

The core advantage of the UK and listed-vehicle shift is not geography by itself. It is a change in access to value. Spring says so directly: investments in listed companies and funds offer liquidity and diversification, and let the company access venture, growth, and private-investment exposure through the public market. In Molten's case, that means exposure to a platform focused on private technology companies in the UK and Europe, with more than 80 portfolio companies across stages.

Against the private book, that is a real strength. Private holdings depend on fundraising rounds, shareholder agreements, exit markets, and buyer appetite. A listed investment vehicle is more volatile, but it gives a quoted market price and faster capital reallocation. So if Spring wants to stay in technology while shortening the distance between value creation and possible realization, the move makes sense.

The choice of market is also not random. In its discussion of UK venture capital, the company describes a market that remained Europe's leader in 2025, with venture investment of $23.6 billion, up about 35% from 2024, and with capital increasingly concentrated around larger deals, especially AI. That is not proof that the public UK bucket will outperform. But it is proof that the company is not tilting into a marginal venue. It is leaning into Europe's leading venture market.

There is one more point in the strategy's favor. This is not a balance-sheet-forced move. Spring says it finances its activity mainly from its own resources, and it ended 2025 with working capital of NIS 55.2 million. So the UK pivot looks like a deliberate capital-allocation decision, not a forced liquidity response.

Why it still looks more like imported beta

This is the real test. If the UK pivot is genuinely a new return engine, the company needs to show that it creates repeatable value, or at least value that is easier to capture in cash. In 2025, that still did not happen.

First, annual net profit was NIS 3.4 million, but the real earnings engine was gains from investments, net, and finance income of NIS 10.55 million. Service revenue was only NIS 1.06 million. Inside investment gains, the gain from quoted securities was NIS 7.37 million, and about NIS 4.95 million of that came from listed technology companies and funds in England. Molten alone contributed NIS 4.37 million. So in the first proof year of the pivot, almost half of the investment-gain line came from the public UK tech basket, and about 41% came from Molten alone.

Second, that proof was heavily second-half loaded. Gains from investments, net, and finance income were NIS 1.99 million in the first half and NIS 8.56 million in the second half. Net profit itself was only NIS 432 thousand in the first half, versus NIS 2.99 million in the second half. That does not invalidate the strategy, but it does mean 2025 still does not show a smooth, durable engine. It shows a year in which a stronger public-market backdrop in the second half lifted the result.

Most of the 2025 proof arrived in the second half

Third, this is still a P&L story more than a cash story. Operating cash flow was negative NIS 2.18 million because accounting profit was reduced by non-cash income, mainly the NIS 7.37 million gain from quoted securities. Investing cash flow was also negative, at NIS 2.01 million. So in 2025, the public UK strategy did improve reported earnings, but it did not yet prove that it is building a new cash-return layer for shareholders.

Fourth, and most important for the next read, the imported beta is already visible in the filing. The company does not use derivatives to hedge exposures. Under its own sensitivity analysis, a 5% move in sterling changes profit by NIS 1.17 million. That is about 34% of annual net profit. A 5% move in security prices changes profit by NIS 3.75 million, more than the entire 2025 net profit. Once Spring shifts more weight toward London and toward listed investment vehicles, it is importing not only opportunity but also nearly direct accounting volatility.

Imported beta is already large relative to net profit

The final yellow flag is discipline. The company says it intends to expand investments in private and listed technology companies and funds, but also states that there are no specific investment criteria and that each investment is examined on its own merits. That is an important disclosure. It means the strategic direction is clear, but the market still does not have a hard framework: what level of concentration is acceptable, what return threshold matters, when the company sells, and how much FX exposure it is willing to carry. Without that, it is hard to argue that a true return engine has already been built. For now, this looks more like managerial flexibility than a disclosed capital-allocation system.

The real 2026 test

If Spring wants to prove that the UK tilt is more than imported beta, three tests matter:

TestWhat needs to happenWhy it matters
Realization or cashRealizations, dividends, or actual cash coming from the public bucketWithout that, value remains mostly mark-to-market
Allocation disciplineClear guardrails on concentration, pace of expansion, and FX exposureWithout discipline, success depends more on market conditions than on process
Genuine diversificationLess dependence on a single holding like MoltenOtherwise, a "public basket" is less diversified than it sounds

The main friction is not the UK itself. It is the gap between liquidity and value capture. Liquidity is already here. Daily pricing is already here. Accounting profit has already shown up. What remains unproven is whether this strategy can generate repeatable value, send cash back, and hold up through a period when London or sterling move the wrong way.

Conclusion

The current thesis on this issue is fairly sharp: the UK pivot and the move into Molten became material in 2025, but they still do not look like a proven return engine. What works today is the ability to buy more liquid exposure to the European technology ecosystem than the private book alone can provide. What still weighs on the thesis is that the proof so far came through mark-to-market gains, FX exposure, and concentration.

That matters because it changes how Spring should be read. The company is no longer only a private-book story. It is increasingly a capital-allocation story whose earnings can move with public-market sentiment, liquidity, and currency. In 2025, the answer still leans more toward imported beta than toward fully demonstrated value capture.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction